Genetic Testing Technology Among Assets Acquired by Labcorp from Invitae
Labcorp has acquired select assets from Invitae to enhance its genetic testing technology and improve its personalized care abilities.
Read MorePosted by Chris Wolski | Aug 5, 2024 | Company News |
Labcorp has acquired select assets from Invitae to enhance its genetic testing technology and improve its personalized care abilities.
Read MorePosted by Andy Lundin | Aug 1, 2024 | Sepsis |
Advances in AI and data science highlight innovative machine learning models that predict patient outcomes in multiple myeloma and sepsis.
Read MorePosted by Andy Lundin | Jul 30, 2024 | Blood Gas Analyzers |
Werfen introduced the GEM Premier 7000 with iQM3, the first POC blood gas testing system with hemolysis detection, at ADLM 2024.
Read MorePosted by Chris Wolski | Jul 24, 2024 | Analytical Software Systems |
Proscia has launched an updated version of Concentriq AP, enhancing AI-enabled pathology workflows to improve understanding of major cancers.
Read MorePosted by Andy Lundin | Jul 23, 2024 | Diagnostic Technologies |
Researchers have developed a new rapid assay that determines whether a virus is infectious or non-infectious.
Read More